Harrow, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Harrow, Inc. (HROW) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.98 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-27
- Harrow, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.98M, a 42.27% increase from fiscal 2023.
- Harrow, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.39M, a 17.68% increase from fiscal 2022.
- Harrow, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $1.18M, a 50.11% decline from fiscal 2021.
- Harrow, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $2.37M, a 274.25% increase from fiscal 2020.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 0 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $1.98M 10-K · filed 2025-03-27 | ||
| 2023-12-31 | $1.39M 10-K · filed 2025-03-27 | ||
| 2022-12-31 | $1.18M 10-K · filed 2024-03-19 | ||
| 2021-12-31 | $2.37M 10-K · filed 2023-03-23 | ||
| 2020-12-31 | $633.00K 10-K · filed 2022-03-10 | ||
| 2019-12-31 | $521.00K 10-K · filed 2021-03-08 | $500.00K 10-K · filed 2020-03-13 | |
| 2018-12-31 | $3.70M 10-K · filed 2020-03-13 | ||
| 2017-12-31 | $7.10M 10-K · filed 2019-03-12 | $7.10K 10-K · filed 2018-03-08 | |
| 2017-12-27 | $8.06M 10-K · filed 2019-03-12 | ||
| 2016-12-31 | $7.20K 10-K · filed 2018-03-08 | $7.40M 10-K · filed 2017-03-21 | |
| 2015-12-31 | $5.20M 10-K · filed 2017-03-21 | $4.90M 10-K · filed 2016-03-23 | |
| 2014-12-31 | $3.90M 10-K · filed 2016-03-23 | ||
| 2013-12-31 | $3.00M 10-K · filed 2015-03-12 | ||
| 2012-12-31 | $1.10M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |